CHMG trades 9.7% below Wall Street's consensus target of $93.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CHMG achieves its forward estimates and maintains a stable P/E multiple of 10.1x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, Chemung Financial Corporation (CHMG) has a Wall Street consensus price target of $93.00, based on estimates from 7 covering analysts. With the stock currently trading at $84.75, this represents a potential upside of +9.7%. The company has a market capitalization of $408M.
Analyst price targets range from a low of $90.00 to a high of $96.00, representing a 6% spread in expectations. The median target of $93.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CHMG trades at a trailing P/E of 10.7x and forward P/E of 10.1x. Analysts expect EPS to grow +5.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $121.18, with bear and bull scenarios of $76.34 and $159.67 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CZWICitizens Community Bancorp, Inc. | $225M | $23.38 | $24.00 | +2.7% | Buy | 15.0x | 3 |
 FUNCFirst United Corporation | $296M | $45.92 | $49.50 | +7.8% | Buy | 10.2x | 1 |
 PBHCPathfinder Bancorp, Inc. | $103M | $16.71 | — | — | — | — | — |
 CFFIC&F Financial Corporation | $342M | $105.12 | $115.00 | +9.4% | Buy | 11.0x | 1 |
 AROWArrow Financial Corporation | $636M | $38.47 | $45.00 | +17.0% | Buy | 10.8x | 1 |
 NBTBNBT Bancorp Inc. | $2.7B | $52.83 | $57.67 | +9.2% | Hold | 12.6x | 10 |
 STBAS&T Bancorp, Inc. | $1.8B | $50.78 | $53.50 | +5.4% | Hold | 12.4x | 12 |
 FXNCFirst National Corporation | $275M | $30.42 | $21.00 | -31.0% | Buy | 11.6x | 1 |
 TRSTTrustCo Bank Corp NY | $976M | $57.30 | — | — | Hold | 20.0x | 3 |
 FISFidelity National Information Services, Inc. | $14.8B | $28.73 | $42.93 | +49.4% | Hold | 4.6x | 40 |
Quick answers to the most common questions about buying CHMG stock.
The consensus price target for CHMG is $93, close to the current price of $84.75 (9.7% implied move). Based on 7 analyst estimates, the stock appears fairly valued near current levels.
CHMG has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $93 implies 9.7% upside from current levels.
With a forward P/E of 10.0677x, CHMG trades at a relatively low valuation. The consensus target of $93 implies 9.7% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $96 for CHMG, while the most conservative target is $90. The consensus of $93 represents the median expectation. Our quantitative valuation model projects a bull case target of $160 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CHMG is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CHMG stock forecast based on 7 Wall Street analysts shows a consensus price target of $93, with estimates ranging from $90 (bear case) to $96 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $121, with bear/bull scenarios of $76/$160.
Our quantitative valuation model calculates CHMG's fair value at $121 (base case), with a bear case of $76 and bull case of $160. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
CHMG trades at a forward P/E ratio of 10.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 10.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
CHMG appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $93 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CHMG analyst price targets range from $90 to $96, a 6% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $93 consensus represents the middle ground. Our model's $76-$160 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.